Nuzenio

Argenx

Argenx news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 23 latest news signals 15 publisher sources 100/100 entity strength

Latest news

Argenx Announces Commencement Of Tender Offer To Acquire Forte Biosciences, Inc. >ARGX.BT - MoomooMoomoo · Fri, 07 Aug 2026 03:39:31 GMTForte Biosciences (FBRX) faces $77 per share cash tender offer from argenx - Stock TitanStock Titan · Thu, 06 Aug 2026 12:08:47 GMTargenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc. - Investing News NetworkInvesting News Network · Thu, 06 Aug 2026 11:45:00 GMTargenx to acquire Forte Biosciences (NASDAQ: FBRX) in $77 cash tender - Stock TitanStock Titan · Thu, 06 Aug 2026 11:18:43 GMTargenx (ENXTBR:ARGX) After Its Zacks Upgrade What Does The Valuation Narrative Say - simplywall.stsimplywall.st · Thu, 06 Aug 2026 00:48:11 GMTArgenx SE (ARGX) Prepares to Demonstrate Vyvgart’s Efficacy in Broader Autoimmune Diseases - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 15:35:40 GMTargenx (ARGX) calls September 17 EGM to add two non-executive directors - Stock TitanStock Titan · Mon, 03 Aug 2026 20:13:40 GMTargenx announces Extraordinary General Meeting of Shareholders on September 17, 2026 - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 20:01:00 GMT

Timeline

Fri, 07 Aug 2026 03:39:31 GMTArgenx Announces Commencement Of Tender Offer To Acquire Forte Biosciences, Inc. >ARGX.BT - Moomoo
Thu, 06 Aug 2026 12:08:47 GMTForte Biosciences (FBRX) faces $77 per share cash tender offer from argenx - Stock Titan
Thu, 06 Aug 2026 11:45:00 GMTargenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc. - Investing News Network
Thu, 06 Aug 2026 11:18:43 GMTargenx to acquire Forte Biosciences (NASDAQ: FBRX) in $77 cash tender - Stock Titan
Thu, 06 Aug 2026 00:48:11 GMTargenx (ENXTBR:ARGX) After Its Zacks Upgrade What Does The Valuation Narrative Say - simplywall.st
Tue, 04 Aug 2026 15:35:40 GMTArgenx SE (ARGX) Prepares to Demonstrate Vyvgart’s Efficacy in Broader Autoimmune Diseases - Yahoo Finance

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Argenx.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

15 distinct publisher/source names are currently connected to this entity page.